TEMOZOLOMIDE 180mg (Temozolomide 180 mg)
Pill with imprint TEMOZOLOMIDE 180mg is White, Capsule-shape and has been identified as Temozolomide 180 mg. It is supplied by Sandoz Inc.
Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 180 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEMOZOLOMIDE 180mg
Temozolomide
- Imprint
- TEMOZOLOMIDE 180mg
- Strength
- 180 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sandoz Inc.
- National Drug Code (NDC)
- 00781-2695
- Inactive Ingredients
-
shellac,
alcohol,
isopropyl alcohol,
butyl alcohol,
propylene glycol,
ammonia,
D&C Red No. 7 Calcium Lake,
FD&C Yellow No. 6,
titanium dioxide,
sodium lauryl sulfate
Note: Inactive ingredients may vary.
Related images for "TEMOZOLOMIDE 180mg"
More about temozolomide
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (8)
- Drug images
- Pricing & coupons
- En español
- Drug class: alkylating agents
Patient resources
- Drug Information
- Temozolomide (Advanced Reading)
- Temozolomide Intravenous (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.